top of page

Medigene to Present at Upcoming Conferences

Planegg/Martinsried, February 19, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the 7th CAR-TCR Summit Europe taking place February 27-29, 2024, in London as well as at the East-West Biopharma Summit to… Medigene to Present at Upcoming Conferences

Aktuelle Beiträge

Alle ansehen

Comments


bottom of page